Results 121 to 130 of about 17,658 (183)

Correction: One-Year Outcomes of Faricimab in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report. [PDF]

Ophthalmol Ther
Tillmann A, Stillenmunkes R, Garweg JG, Cattaneo J, Bartolomeo N, Grimaldi G, Spitznagel T, De Oliveira Figueiredo EC, Ambresin A, Menghini M, Somfai GM, Zweifel S, Fröhlich J, Artemiev D, Ebneter A, Hatz K, Weinberger A, Pfister IB, Schild C, Eandi C, Munk MR, Swiss Retina Research Network.   +21 more
europepmc   +1 more source

Increased intraocular pressure immediately after aflibercept 8 mg intravitreal injection for neovascular age-related macular degeneration. [PDF]

Graefes Arch Clin Exp Ophthalmol
Hashiya N, Maruko I, Maruko R, Kakehashi M, Kawahara K, Nishihara S, Iida T.   +6 more
europepmc   +1 more source

Association between screening duration and treatment outcomes in the clinical trials of ranibizumab and aflibercept for neovascular age-related macular degeneration. [PDF]

Sci Rep
Kim HM, Woo SJ.
europepmc   +1 more source

Age-Specific Increases in the Prevalence and Treatment Burden of Neovascular Age-Related Macular Degeneration in a Super-Aged Society. [PDF]

Invest Ophthalmol Vis Sci
Akada M, Ideyama M, Kido A, Miyata M, Ueda-Arakawa N, Tamura H, Ooto S, Miyake M, Tsujikawa A, Hata M.   +9 more
europepmc   +1 more source

Massive Submacular Hemorrhage Following Intravitreal Faricimab Injection for Neovascular Age-Related Macular Degeneration. [PDF]

Cureus
Kaganovski A, Rostomian N, Shrier E.
europepmc   +1 more source

Real-world treatment outcomes of aflibercept versus bevacizumab for neovascular age-related macular degeneration. [PDF]

Graefes Arch Clin Exp Ophthalmol
Mhmud H, Vermeulen JP, Adanc B, Klevering JBJ, Groenink-Lindenhovius C, Tigchelaar OAM, Ponsioen TL, Klaver CCW, Witmer AN.   +8 more
europepmc   +1 more source

Efficacy of brolucizumab and ranibizumab in diabetic macular edema and neovascular age-related macular degeneration: insights from a case series. [PDF]

Ann Med Surg (Lond)
Hossain B, Rahmatullah S, Ahmed T.
europepmc   +1 more source

Therapeutic Equivalence of Eyluxvi (Aflibercept) to Eylea in Neovascular Age-Related Macular Degeneration: ALTERA Trial (Randomized). [PDF]

Ophthalmol Ther
Raczynska D, Ernest J, Baumane K, Sagong M, Akiyama K, Rauschning W, Vajas A, Nowosielska A, Dusova J, Majtánová N, Oleksy P, Kuneva I, Resch M, Lange N, Briede E, Bajdik B, Jeong A, Kozub B, Papp A.   +18 more
europepmc   +1 more source

Short term real-world effectiveness of faricimab in neovascular age-related macular degeneration patients in the Republic of Korea. [PDF]

Sci Rep
Chung DH, Jee D, Roh YJ, Ra H, Lee MY, Won JY, Shin JA, Jung SH, Park YH.   +8 more
europepmc   +1 more source

Integrating genetics, age and imaging to predict treatment outcomes in neovascular age-related macular degeneration: a proof-of-concept study. [PDF]

Sci Rep
Moghul I, Pontikos N, Sharma A, Liu T, Soomro T, Wagner SK, Silva AS, Zhang G, Naik G, Bagga P, Chan YW, Keane PA, Cipriani V, Sivaprasad S, Webster AR, Balaskas K.   +15 more
europepmc   +1 more source